Urology
2004-09-01
Current and new strategies in immunotherapy for superficial bladder cancer.
Frank G E Perabo, Stefan C Müller
文献索引：Urology 64(3) , 409-21, (2004)
全文：HTML全文
摘要
相关文献：
CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonists.
2014-12-01
[J. Immunol. Methods 414 , 82-90, (2014)]
Bropirimine, an orally active anticancer agent for superficial bladder cancer.
1998-08-01
[Eur. Urol. 34(2) , 107-10, (1998)]
Paclitaxel, bropirimine and linomide: effect on growth inhibition in a murine prostate cancer model by different growth regulatory mechanisms.
1998-03-01
[Methods Find. Exp. Clin. Pharmacol. 20(2) , 111-4, (1998)]
Bropirimine as neoadjuvant therapy decreases residual disease and expression of markers PCNA and TGF-beta 1 in a rat orthotopic prostate adenocarcinoma.
1997-05-01
[Methods Find. Exp. Clin. Pharmacol. 19(4) , 261-7, (1997)]
Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.
2000-02-01
[Eur. J. Pharm. Sci. 9(4) , 381-6, (2000)]